Francesco La Torre
Francesco La Torre publishes mostly in Hematology, Rheumatology and Spectroscopy, on topics such as Autoimmune and Inflammatory Disorders Research, Analytical Chemistry and Chromatography and Inflammasome and immune disorders.
- World rank
- #737,907 of 7,710,434 ranked researchers
- Rank in Italy
- #22,122 of 242,206
- Works
- 260
- Citations
- 5.7k
- Citations per work
- 22.0
What does Francesco La Torre research?
Francesco La Torre's work is mostly in Medicine (30%), Chemistry (8%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else14455.3%
- Health Sciences7830.0%
- Medicine7830.0%
- Physical Sciences207.8%
- Chemistry207.8%
- Life Sciences186.9%
- 1Hematology9% of their works
- 2Rheumatology9% of their works
- 3Spectroscopy8% of their works
- 4Surgery7% of their works
- 5Molecular Biology7% of their works
- 6Ophthalmology5% of their works
Research topics
- Autoimmune and Inflammatory Disorders Research
- Analytical Chemistry and Chromatography
- Inflammasome and immune disorders
- Ocular Diseases and Behçet’s Syndrome
- Kawasaki Disease and Coronary Complications
- Microfluidic and Capillary Electrophoresis Applications
- Spondyloarthritis Studies and Treatments
- Otitis Media and Relapsing Polychondritis
Which keywords describe Francesco La Torre's research?
The keywords of their largest research topics: Juvenile Idiopathic Arthritis, Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, Epidemiology, Chiral Separation, Liquid Chromatography, Inflammasome and NLRP3.
- VEXAS Syndrome
- Spondyloarthritis
- Poly(dimethylsiloxane)
- Multisystem Inflammatory Syndrome
- Uveitis
- NLRP3
- Liquid Chromatography
- Epidemiology
- Hemophagocytic Lymphohistiocytosis
- Juvenile Idiopathic Arthritis
- Macrophage Activation Syndrome
- Chiral Separation
- Inflammasome
- Behçet's Disease
- Kawasaki Disease
- Lab-on-a-Chip
- Ankylosing Spondylitis
- Relapsing Polychondritis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Juvenile Idiopathic Arthritis902 topics
- Hemophagocytic Lymphohistiocytosis611 topic
- Macrophage Activation Syndrome611 topic
- Epidemiology552 topics
- Chiral Separation381 topic
- Liquid Chromatography381 topic
- Inflammasome341 topic
- NLRP3341 topic
- Behçet's Disease291 topic
- Uveitis291 topic
- Kawasaki Disease261 topic
- Multisystem Inflammatory Syndrome261 topic
- Lab-on-a-Chip181 topic
- Poly(dimethylsiloxane)181 topic
- Ankylosing Spondylitis151 topic
- Spondyloarthritis151 topic
- Relapsing Polychondritis141 topic
- VEXAS Syndrome141 topic
Where does Francesco La Torre work?
Francesco La Torre's main affiliation in the publication record is Ospedale Pediatrico Giovanni XXIII, Italy.
How many publications and citations does Francesco La Torre have?
OpenAlex counts 260 works and 5,726 citations for Francesco La Torre, an h-index of 39, ranking #737,907 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Francesco La Torre
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Francesco La Torre. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.